Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi

Chest. 2007 Jan;131(1):230-6. doi: 10.1378/chest.06-0767.

Abstract

Background: Invasive aspergillosis (IA) is a common fungal infection in immunocompromised patients and has a high mortality rate. Among patients with IA, Aspergillus terreus infections have become a growing concern in the past few years.

Objective: To determine the clinical risk factors for isolation of and respiratory infection by A terreus in patients with culture findings positive for filamentous fungi.

Methods: Cohort study of 505 consecutive isolates of filamentous fungi in 332 patients from one center. A terreus was present in 46 isolates from 40 patients (9.1%). Clinical histories were reviewed to identify the risk factors related to isolation of and infection by A terreus, which were grouped into three categories (ie, host factors, factors related to immunosuppression, and factors related to hospitalization), and were analyzed using a multiple logistic regression model.

Results: A total of 192 of 505 isolates studied (38%) were due to invasive respiratory infection. A total of 27 of 46 cultures (58.7%) that were positive for A terreus were due to invasive infection (odds ratio [OR], 2.53; 95% confidence interval [CI], 1.37 to 4.69; p = 0.034). The factors associated with invasive A terreus infection were prophylactic use of amphotericin B aerosols (OR, 27.8; 95% CI, 6.7 to 109.7; p = 0.001) and mechanical ventilation (OR, 3.3; 95% CI, 1.02 to 10.9; p = 0.04). Transplantation was associated with a lower risk of A terreus infection (OR, 0.2; 95% CI, 0.046 to 0.789; p = 0.02).

Conclusions: In patients with culture findings positive for filamentous fungi, the prophylactic use of amphotericin B aerosols and mechanical ventilation are associated with a higher risk of A terreus infections. In these patients, transplantation is associated with a lower risk of isolation and respiratory infection by A terreus.

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Adult
  • Aerosols
  • Aged
  • Aged, 80 and over
  • Amphotericin B / administration & dosage
  • Antibiotic Prophylaxis
  • Antifungal Agents / administration & dosage
  • Aspergillosis / diagnosis*
  • Aspergillosis / microbiology*
  • Aspergillosis / prevention & control
  • Aspergillus / isolation & purification
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunocompromised Host
  • Infant
  • Lung Diseases, Fungal / diagnosis*
  • Lung Diseases, Fungal / prevention & control
  • Male
  • Middle Aged
  • Opportunistic Infections / diagnosis*
  • Opportunistic Infections / microbiology*
  • Opportunistic Infections / prevention & control
  • Retrospective Studies
  • Risk Factors

Substances

  • Aerosols
  • Antifungal Agents
  • Amphotericin B